Humana Inc (HUM)


Humana Inc. is a U.S.-based healthcare company listed on the NYSE under the ticker HUM. As a common equity security, it represents ordinary shares in the company. Humana focuses on medical and specialty insurance products and operates through two segments: Insurance and CenterWell. Its Insurance business includes Medicare Advantage plans, stand-alone Medicare prescription drug plans, Medicare supplement coverage, and specialty products such as dental, vision, life, and disability insurance, along with administrative services for military health programs and pharmacy benefit management. The CenterWell segment provides senior-focused primary care, home health services, post-acute care coordination, pharmacy solutions, and hospice care. Founded in 1961 and headquartered in Louisville, Kentucky, the company adopted the Humana name in 1974.


Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-HUM
$456.62
12.7% Upside
Fair
$346.71
-14.4% Downside
Fair
Good
June 26, 2026
July 31, 2026
3.54
0.9%
July 29, 2026
43.0x
2.6x
0.4x
47.808 B
56.735 B
23.1%
99.8%
5.6
38.0%
112.6%
Valuation • Fair Value

Humana Inc (NYSE-HUM) Fair Value by Valuation Model

Compare the primary fair value estimate for Humana Inc (NYSE-HUM) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$456.62

Estimated upside of 12.7% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

NM

Discounted cash flow valuation reference.

Ben Graham Formula Value

$104.43

Classic Ben Graham valuation formula reference.

DDM Fair Value

$458.29

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

$455.51

Comparable-company valuation reference.

Analyst Price Target

$346.71

Analysts imply downside of 14.4%.

How to read these valuation models

Use this section to compare the primary fair value estimate for Humana Inc (NYSE-HUM) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Humana Inc (NYSE-HUM)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

137.2 B

Current operating scale indicator.

Revenue Forecast

162.3 B

Forward revenue estimate.

EBITDA

3.362 B

Current operating profitability reference.

EBITDA Forecast

2.848 B

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Humana Inc (NYSE-HUM) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Humana Inc (NYSE-HUM)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Good

Positive financial-health read.

Piotroski Score

6

Mid-range quality score.

Beneish M-Score

-2.37

No elevated caution signal from this screen.

Altman Z-Score

5.6

Relatively strong balance-sheet zone.

FCF / Net Income

112.6%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Humana Inc (NYSE-HUM). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Humana Inc (NYSE-HUM)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

July 29, 2026

Days to Earnings

8

Dividend Payment Date

July 31, 2026

Ex-Dividend Date

June 26, 2026

Dividend Yield

0.9%

Income yield reference.

Upcoming Dividend

3.54

Upcoming distribution amount.

Payment Type

Cash

Distribution type as reported in the data.

Dividend Currency

USD

Currency used for the distribution.

Payout Ratio

38.0%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Humana Inc (NYSE-HUM), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Humana Inc (NYSE-HUM) Stock Forecast & Technical Outlook

Review Humana Inc (NYSE-HUM) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for Humana Inc (NYSE-HUM) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for Humana Inc (NYSE-HUM) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for Humana Inc (NYSE-HUM) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Humana Inc (NYSE-HUM) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Humana Inc (NYSE-HUM) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Humana Inc (NYSE-HUM)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Hold

Based on the available recommendation mix, Humana Inc (NYSE-HUM) has a Hold consensus, with 8 buy, 15 hold and 2 sell recommendations in the current data set.

Buy 8
Hold 15
Sell 2
FAQ Fast Investor Answers

Humana Inc (NYSE-HUM) Stock FAQ

Quick answers about Humana Inc (NYSE-HUM) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$456.62
Estimated upside 12.7%
Valuation Rating
Undervalued
Estimated upside of 12.7%
Analyst Target
$346.71
Implied downside 14.4%
Financial Health
Good
Current financial-health read

The current fair value estimate for Humana Inc (NYSE-HUM) is $456.62. This implies an estimated upside of 12.7% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 12.7% versus the current market price.

The available analyst price target for Humana Inc (NYSE-HUM) is $346.71. The analyst target implies estimated downside of 14.4%.

The current financial health read for Humana Inc (NYSE-HUM) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Humana Inc (NYSE-HUM) is July 29, 2026.

Based on the current data, dividend yield is 0.9%, upcoming dividend amount is 3.54, ex-dividend date is June 26, 2026, payment date is July 31, 2026.

The current P/E ratio listed for Humana Inc (NYSE-HUM) is 43.0x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Humana Inc is 47.808 B.

The current enterprise value listed for Humana Inc is 56.735 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Humana Inc is NYSE-HUM, and the stock is listed on NYSE.

Humana Inc (NYSE-HUM) is listed on NYSE.

The current debt-to-total-capital ratio listed for Humana Inc is 23.1%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Humana Inc is 99.8%. Free float helps investors understand how much of the share base is available for public trading.